FDA Approves Corlanor for Chronic Heart Failure

Share this content:
FDA Approves Corlanor for Chronic Heart Failure
FDA Approves Corlanor for Chronic Heart Failure

(HealthDay News) -- Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure, the agency said in a news release.

It is recommended that people who take Corlanor have a stable resting heartbeat of at least 70 beats per minute and take beta-blocker medication at the highest tolerable dose, the FDA said.

The drug was evaluated in a clinical trial of 6,505 people. The most common side effects included bradycardia, hypertension, atrial fibrillation, and temporary vision disturbance (flashes of light). Users should contact a doctor without delay if they have symptoms such as irregular heartbeat, a feeling that the heart is racing or pounding, have chest pressure, or worsening shortness of breath. Women who are pregnant or expect to become pregnant should avoid the drug, the FDA said.

"Heart failure is a leading cause of death and disability in adults," Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research, said in a statement. "Corlanor is thought to work by decreasing heart rate and represents the first approved product in this drug class."

Corlanor is manufactured by Amgen, based in Thousand Oaks, Calif.

More information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »